Atsuko Watanabe
Comptroller/Controller/Auditor at HanaVax, Inc.
Atsuko Watanabe active positions
| Companies | Position | Start | End |
|---|---|---|---|
HanaVax, Inc.
 HanaVax, Inc. BiotechnologyHealth Technology HanaVax, Inc. develops nasal vaccine against infectious diseases. It develops pneumococcal nasal vaccine to prevent pneumonia, sepsis and otitis media. The company was founded by Hosei Ou on December 27, 2017 and is headquartered in Tokyo, Japan. | Comptroller/Controller/Auditor | 31/10/2018 | - |
Career history of Atsuko Watanabe
Former positions of Atsuko Watanabe
| Companies | Position | Start | End |
|---|---|---|---|
| ONCOTHERAPY SCIENCE, INC. | Director/Board Member | 31/05/2019 | - |
| Corporate Officer/Principal | 30/04/2019 | - |
Statistics
International
| Japan | 3 |
Operational
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
| Comptroller/Controller/Auditor | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ONCOTHERAPY SCIENCE, INC. | Health Technology |
| Private companies | 1 |
|---|---|
HanaVax, Inc.
HanaVax, Inc. BiotechnologyHealth Technology HanaVax, Inc. develops nasal vaccine against infectious diseases. It develops pneumococcal nasal vaccine to prevent pneumonia, sepsis and otitis media. The company was founded by Hosei Ou on December 27, 2017 and is headquartered in Tokyo, Japan. | Health Technology |
- Stock Market
- Insiders
- Atsuko Watanabe
- Experience
